Elevated bone resorption markers in a patient with hypercalcemia associated with post-partum thyrotoxicosis and hypoadrenocorticism due to pituitary failure

Journal of Endocrinological Investigation

Volumn 27, Issue 8, 2004, Pages 782-787

  Fujikawa, Memi ^a   Kamihira, K ^a   Sato, K ^a   Okamura, K ^a   Kidota, S ^a   Lida, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Bone resorption; Glucocorticoid deficiency; Hypercalcemia; Thyrotoxicosis

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DEOXYPYRIDINOLINE; GLUCOCORTICOID; HYDROCORTISONE; POTASSIUM IODIDE; PYRIDINOLINE; SODIUM CHLORIDE; THIAMAZOLE; THYROID HORMONE;

ADULT; ANOREXIA; ARTICLE; CASE REPORT; CONSCIOUSNESS DISORDER; DELIVERY; DISEASE EXACERBATION; FATIGUE; FEMALE; FEVER; GESTATIONAL AGE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPOPHYSITIS; HYPOPITUITARISM; LYMPHOCYTIC INFILTRATION; MUSCULOSKELETAL DISEASE; OSTEOLYSIS; PUERPERIUM; SYMPTOMATOLOGY; TACHYCARDIA; THYROID HORMONE BLOOD LEVEL; THYROIDITIS; THYROTOXICOSIS;

EID: 10244250421     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347524     Document Type: Article

References (33)

1. Richtsmeier AJ, Henry RA, Bloodworth Jr JMB, Ehrlich EN. Lymphoid hypophysitis with selective adrenocorticotropic hormone deficiency. Arch Intern Med 1980, 140: 1243-5.
2. Jensen MD, Handwerger BS, Scheithauer BW, Carpenter PC, Mirakian R, Banks PM. Lymphocytic hypophysitis with isolated corticotropin deficiency. Ann Intern Med 1986, 105: 200-3.
3. Miell J, McGregor A, Butler J, Ross R. Life-threatening hypercalcemia in association with Addisonian crisis. Postgrad Med J 1991, 67: 770-2.
4. Vasikaran SD, Tallis GA, Braund WJ. Secondary hypoadrenalism presenting with hypercalcemia. Clin Endocrinol (Oxf) 1994, 41: 261-4.
5. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993, 39: 635-40.
6. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinium crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991, 6: 639-44.
7. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994, 9: 1643-9.
8. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992, 7: 1251-8.
9. Parfitt AM, Simon LS, Villanueva AR, Krane SM. Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 1987, 2: 427-36.
10. Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients of bone disease. J Clin Invest 1980, 66: 878-83.
11. Peterson RE. The miscible pool and tumover rate of adrenocortical steroids in man. Recent Prog Horm Res 1959, 15: 231-74.
12. Shapiro MS, Trebich C, Shilo L, Shenkman L. Myalgias and muscle contractures as the presenting signs of Addison's disease. Postgrad Med J 1988, 64: 222-3.
13. Jowsey J, Simons GW. Normocalcaemia in relation to cortisone secretion. Nature 1968, 217: 1277-9.
14. Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. BMJ 1973, 4: 643-6.
15. Muls E, Bouillon R, Boelaert J, et al. Etiology of hypercalcemia in a patient with Addison's disease. Calcif Tissue Int 1982, 34: 523-6.
16. Montoli A, Colussi G, Minetti L. Hypercalcemia in Addison's disease: calcitropic hormone profile and bone histology. J Intern Med 1992, 232: 535-40.
17. Raisz LG, Kream BE. Regulation of bone formation. N Engl J Med 1983, 309: 29-35, 83-9.
18. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990, 112: 352-64.
19. Shalhoub V, Conlon D, Tassinari M, et al. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 1992, 50: 425-40.
20. Tobias J, Chambers TJ. Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. Endocrinology 1989, 125: 1290-5.
21. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990, 144: 4226-30.
22. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD. IL-1 and TNF stimulate the formation of human osteoclast like cells in vitro. J Bone Miner Res 1989, 4: 113-8.
23. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990, 145: 3297-303.
24. Allain TJ, McGregor AM. Thyroid hormones and bone. J Endocrinol 1993, 139: 9-18.
25. Baran DT. The skeletal system in thyrotoxicosis. In: Braverman LE, Utinger RD eds. The thyroid, 81th ed. New York: JB Lippincott. 2000, 659-66.
26. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG. Direct stimulation of bone resorption by thyroid hormones. J Clin Invest 1976, 58: 529-34.
27. Klaushofer K, Hoffmann O, Gleispach H, et al. Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J Bone Miner Res 1989, 4: 305-12.
28. Kawaguchi H, Pilbeam CC, Woodiel FN, Raisz LG. Comparison of the effects of 3,5,3′-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae. J Bone Miner Res 1994, 9: 247-53.
29. Abu EO, Bord S, Horner A, Chatterjee VK, Compston JE. The expression of thyroid hormone receptors in human bone. Bone 1997, 21: 137-42.
30. Lakatos P, Stern PH. Evidence for direct non-genomic effects of triiodothyronine on bone rudiments in rats: stimulation of the inositol phosphate second messenger system. Acta Endocrinol (Copenh) 1991, 125: 603-8.
31. Britto JM, Fenton AJ, Holloway WR, Nicholson GC. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994, 134: 169-76.
32. Lakatos P, Stern PH. Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones. Calcif Tissue Int 1992, 50: 123-8.
33. Tarjan G, Stern PH. Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures. J Bone Miner Res 1995, 10: 1321-6.